HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 69.96 +0.97 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.99 | 52 Week High | $18.39 | |||
| Open | $69.38 | 52 Week Low | $6.96 | |||
| Day High | $70.01 | P/E | N/A | |||
| Day Low | $68.93 | EPS | $-0.58 | |||
| Volume | 203,631 | |||||
